Lipiflow and IPL have become mainstays in the treatment of meibomian gland disease. But while they might be effective in some cases, they are also quite expensive to patients. Which begs the question – how effective are lipiflow and IPL when compared to more conventional treatments? Is there a way to predict which patients will benefit most from these treatments? Ultimately, how should Lipiflow and IPL factor into the treatment algorithm for meibomian gland disease in a way that is clinically advantageous while also cost-sensitive to the patient? Dr. Ashley Brissette joins the podcast.

Check out Dr. Brissette's Eye Care Products
www.dailypractice.com

Follow Dr. Brissette on Social Media
Instagram @abrissettemd
TikTok @abrissettemd